# Prospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses

> **NCT01444313** · NA · COMPLETED · sponsor: **Johnson & Johnson Vision Care, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Refractive Errors

## Interventions

- **DEVICE:** narafilcon A contact lens
- **DEVICE:** nelfilcon A soft contact lenses

## Key facts

- **NCT ID:** NCT01444313
- **Lead sponsor:** Johnson & Johnson Vision Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2013-03
- **Final completion:** —
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01444313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01444313, "Prospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01444313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*